Accessing Teva’s in-house documents helped build EU sanction, official says
Teva’s in-house lawyers were involved in the company’s anticompetitive strategy to keep challengers off the market for a multiple sclerosis treatment, according to an EU antitrust investigator, who said it was...To view the full article, register now.
Already a subscriber? Click here to view full article